There are a significant number of men under 40 who experience erectile dysfunction (ED). In the past, the vast majority of cases were thought to be psychogenic in nature. Studies have identified organic etiologies in 15-72% of men with ED under 40. Organic etiologies include vascular, neurogenic, Peyronie's disease (PD), medication side effects and endocrinologic sources. Vascular causes are commonly due to focal arterial occlusive disease. Young men with multiple sclerosis, epilepsy and trauma in close proximity to the spinal cord are at increased risk of ED. It is estimated that 8% of men with PD are under 40, with 21% of these individuals experiencing ED. Medications causing ED include antidepressants, NSAIDs and finasteride (Propecia), antiepileptics and neuroleptics. Hormonal sources are uncommon in the young population, however possible etiologies include Klinefelter's syndrome, congenital hypogonadotropic hypogonadism, and acquired hypogonadotropic hypogonadism. The workup of young men with ED should include a thorough history and physical examination. The significant prevalence of vascular etiologies of ED in young men should prompt consideration of nocturnal penile tumescence testing and penile Doppler ultrasound. Treatment options that may improve ED include exercise and oral PDE-5 inhibitors.

Keywords:
Erectile dysfunction, Peyronie’s disease, Sexual dysfunction, Trauma, Young men, Organic etiology
1.
Shamloul R, Ghanem H: Erectile dysfunction. Lancet 2013;381:153-165.
2.
Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB: Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61.
3.
Caskurlu T, Tasci AI, Resim S, Sahinkanat T, Ergenekon E: The etiology of erectile dysfunction and contributing factors in different age groups in Turkey. Int J Urol 2004;11:525-529.
4.
Karadeniz T, Topsakal M, Aydogmus A, Basak D: Erectile dysfunction under age 40: etiology and role of contributing factors. ScientificWorldJournal 2004;4(suppl 1):171-174.
5.
Donatucci CF, Lue TF: Erectile dysfunction in men under 40: etiology and treatment choice. Int J Impot Res 1993;5:97-103.
6.
Lehmann K, Schöpke W, Hauri D: Subclinical trauma to perineum: a possible etiology of erectile dysfunction in young men. Eur Urol 1995;27:306-310.
7.
Sommer F, Goldstein I, Korda JB: Bicycle riding and erectile dysfunction: a review. J Sex Med 2010;7:2346-2358.
8.
Yao F, Huang Y, Zhang Y, Dong Y, Ma H, Deng C, Lin H, Liu D, Lu K: Subclinical endothelial dysfunction and low-grade inflammation play roles in the development of erectile dysfunction in young men with low risk of coronary heart disease. Int J Androl 2012;35:653-659.
9.
Keller JJ, Liang YC, Lin HC: Association between multiple sclerosis and erectile dysfunction: a nationwide case-control study. J Sex Med 2012;9:1753-1759.
10.
Nikoobakht M, Motamedi M, Orandi A, Meysamie A, Emamzadeh A: Sexual dysfunction in epileptic men. Urol J 2007;4:111-117.
11.
Keller J, Chen YK, Lin HC: Association between epilepsy and erectile dysfunction: evidence from a population-based study. J Sex Med 2012;9:2248-2255.
12.
Mallet R, Tricoire JL, Rischmann P, Sarramon JP, Puget J, Malavaud B: High prevalence of erectile dysfunction in young male patients after intramedullary femoral nailing. Urology 2005;65:559-563.
13.
Rajbabu K, Brown C, Poulsen J: Erectile dysfunction after perineal compression in young men undergoing internal fixation of femur fractures. Int J Impot Res 2007;19:336-338.
14.
Siddiqui MA, Peng B, Shanmugam N, Yeo W, Fook-Chong S, Li Tat JC, Guo CM, Tan SB, Yue WM: Erectile dysfunction in young surgically treated patients with lumbar spine disease: a prospective follow-up study. Spine (Phila Pa 1976) 2012;37:797-801.
15.
Tefekli A, Kandirali E, Erol H, Alp T, Köksal T, Kadioğlu A: Peyronie's disease in men under age 40: characteristics and outcome. Int J Impot Res 2001;13:18-23.
16.
Tal R, Hall MS, Alex B, Choi J, Mulhall JP: Peyronie's disease in teenagers. J Sex Med 2012;9:302-308.
17.
Madeo B, Bettica P, Milleri S, Balestrieri A, Granata AR, Carani C, Rochira V: The effects of citalopram and fluoxetine on sexual behavior in healthy men: evidence of delayed ejaculation and unaffected sexual desire. A randomized, placebo-controlled, double-blind, double-dummy, parallel group study. J Sex Med 2008;5:2431-2441.
18.
Yang C, Tang K, Wang B: Clinical value of serum 5-HT level in diagnosis and treatment of premature ejaculation. Urol Int 2013;90:214-218.
19.
Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, Price VH, Van Neste D, Roberts JL, Hordinsky M, Shapiro J, Binkowitz B, Gormley GJ: Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol 1998;39:578-589.
20.
Irwig MS, Kolukula S: Persistent sexual side effects of finasteride for male pattern hair loss. J Sex Med 2011;8:1747-1753.
21.
Gleason JM, Slezak JM, Jung H, Reynolds K, Van den Eeden SK, Haque R, Quinn VP, Loo RK, Jacobsen SJ: Regular nonsteroidal anti-inflammatory drug use and erectile dysfunction. J Urol 2011;185:1388-1393.
22.
Malik P: Sexual dysfunction in schizophrenia. Curr Opin Psychiatry 2007;20:138-142.
23.
Civardi C, Collini A, Gontero P, Monaco F: Vasogenic erectile dysfunction topiramate-induced. Clin Neurol Neurosurg 2012;114:70-71.
24.
Rochira V, Zirilli L, Orlando G, Santi D, Brigante G, Diazzi C, Carli F, Carani C, Guaraldi G: Premature decline of serum total testosterone in HIV-infected men in the HAART era. PLoS One 2011;6:e28512.
25.
Radicioni AF, Ferlin A, Balercia G, Pasquali D, Vignozzi L, Maggi M, Foresta C, Lenzi A: Consensus statement on diagnosis and clinical management of Klinefelter syndrome. J Endocrinol Invest 2010;33:839-850.
26.
Corona G, Petrone L, Paggi F, Lotti F, Boddi V, Fisher A, Vignozzi L, Balercia G, Sforza A, Forti G, Mannucci E, Maggi M: Sexual dysfunction in subjects with Klinefelter's syndrome. Int J Androl 2010;33:574-580.
27.
Yoshida A, Miura K, Nagao K, Hara H, Ishii N, Shirai M: Sexual function and clinical features of patients with Klinefelter's syndrome with the chief complaint of male infertility. Int J Androl 1997;20:80-85.
28.
Young J: Approach to the male patient with congenital hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2012;97:707-718.
29.
Aydogan U, Aydogdu A, Akbulut H, Sonmez A, Yuksel S, Basaran Y, Uzun O, Bolu E, Saglam K: Increased frequency of anxiety, depression, quality of life and sexual life in young hypogonadotropic hypogonadal males and impacts of testosterone replacement therapy on these conditions. Endocr J 2012;59:1099-1105.
30.
Bouvattier C, Mignot B, Lefèvre H, Morel Y, Bougnères P: Impaired sexual activity in male adults with partial androgen insensitivity. J Clin Endocrinol Metab 2006;91:3310-3315.
31.
Salenave S, Trabado S, Maione L, Brailly-Tabard S, Young J: Male acquired hypogonadotropic hypogonadism: diagnosis and treatment. Ann Endocrinol (Paris) 2012;73:141-146.
32.
Fraietta R, Zylberstejn DS, Esteves SC: Hypogonadotropic hypogonadism revisited. Clinics (São Paulo) 2013;68(suppl 1):81-88.
33.
Taskinen S, Hovatta O, Wikström S: Sexual development in patients treated for cryptorchidism. Scand J Urol Nephrol 1997;31:361-364.
34.
Huang Y, Pan L, Xia X, Feng Y, Jiang C, Cui Y: Long-term effects of phytoestrogen daidzein on penile cavernosal structures in adult rats. Urology 2008;72:220-224.
35.
Pan L, Xia X, Feng Y, Jiang C, Cui Y, Huang Y: Exposure of juvenile rats to the phytoestrogen daidzein impairs erectile function in a dose-related manner in adulthood. J Androl 2008;29:55-62.
36.
Siepmann T, Roofeh J, Kiefer FW, Edelson DG: Hypogonadism and erectile dysfunction associated with soy product consumption. Nutrition 2011;27:859-862.
37.
Veronelli A, Masu A, Ranieri R, Rognoni C, Laneri M, Pontiroli AE: Prevalence of erectile dysfunction in thyroid disorders: comparison with control subjects and with obese and diabetic patients. Int J Impot Res 2006;18:111-114.
38.
Heidler S, Temml C, Broessner C, Mock K, Rauchenwald M, Madersbacher S, Ponholzer A: Is the metabolic syndrome an independent risk factor for erectile dysfunction? J Urol 2007;177:651-654.
39.
Martins FG, Abdo CH: Erectile dysfunction and correlated factors in Brazilian men aged 18-40 years. J Sex Med 2010;7:2166-2173.
40.
Elbendary MA, El-Gamal OM, Salem KA: Analysis of risk factors for organic erectile dysfunction in Egyptian patients under the age of 40 years. J Androl 2009;30:520-524.
41.
Tang J, Tang Y, Dai Y, Lu L, Jiang X: The use of intracavernous injection and audiovisual sexual stimulation during real-time pharmacopenile Doppler ultrasonography in vasculogenic erectile dysfunction. Urol Int 2013;90:460-464.
42.
Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D'Andrea F, D'Armiento M, Giugliano D: Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 2004;291:2978-2984.
43.
Hsiao W, Shrewsberry AB, Moses KA, Johnson TV, Cai AW, Stuhldreher P, Dusseault B, Ritenour CW: Exercise is associated with better erectile function in men under 40 as evaluated by the International Index of Erectile Function. J Sex Med 2012;9:524-530.
44.
Evliyaoğlu Y, Yelsel K, Kobaner M, Alma E, Saygılı M: Efficacy and tolerability of tadalafil for treatment of erectile dysfunction in men taking serotonin reuptake inhibitors. Urology 2011;77:1137-1141.
45.
Stryjer R, Spivak B, Strous RD, Shiloh R, Harary E, Polak L, Birgen M, Kotler M, Weizman A: Trazodone for the treatment of sexual dysfunction induced by serotonin reuptake inhibitors: a preliminary open-label study. Clin Neuropharmacol 2009;32:82-84.
46.
Rao DS, Donatucci CF: Vasculogenic impotence. Arterial and venous surgery. Urol Clin North Am 2001;28:309-319.
47.
Munarriz R: Penile microvascular arterial bypass surgery: indications, outcomes, and complications. ScientificWorldJournal 2010;10:1556-1565.
48.
Fugl-Meyer AR, Fugl-Meyer K: Sexual disabilities, problems and satisfaction in 18 74-year-old Swedes. Scand J Sexol 1999;2:79-105.
49.
Béjin A: The epidemiology of premature ejaculation and of its association with erectile dysfunction. Andrologie 1999;9:211-225.
50.
Laumann EO, Paik A, Rosen RC: Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537-544.
51.
Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tejada I, Rodriguez-Vela L, Jimenez-Cruz JF, Burgos-Rodriguez R: Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfunción Eréctil Masculina Study. J Urol 2001;166:569-574.
52.
Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U: Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey'. Int J Impot Res 2000;12:305-311.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.